While ketoacidosis is more likely to occur in a low insulin state, the authors stress the importance of distinguishing T2DM from autoimmune diabetes, which presents with insulin deficiency, before starting a patient on an SGL2 inhibitor, in order to prevent the development of euDKA [14]. Here, INS is linked to type 2 diabetes mellitus.